Patent ID: 7834020

Claim:
A compound which is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride anhydrate in crystalline modification IV (Form IV), wherein said compound exhibits the following XRD data: No. d (Å) 2θ I/I 0 1 9,732 9.08 22 2 6,885 12.85 10 3 6,102 14.50 22 4 5,246 16.89 9 5 4,695 18.89 100 6 4,344 20.43 20 7 4,088 21.72 12 8 3,615 24.61 67 9 3,258 27.35 17 10 3,164 28.18 12.